News & Updates

Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage

20 Mar 2024 by

Clinical outcomes within 1 year of MR-guided stereotactic body radiation therapy (MRgSBRT) with rectal spacer for patients with localized prostate cancer (PC) show excellent tolerability, minimal gastrointestinal (GI) toxicity as well as improved rectal sparing and target coverage vs a non-spacer comparison cohort.

Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage

20 Mar 2024

New pathogen on the block: S. anginosus may promote gastric cancer

19 Mar 2024 by

Streptococcus anginosus induces gastric inflammation, atrophy, and tumorigenesis in mice, researchers from the Chinese University of Hong Kong (CUHK) have reported.

New pathogen on the block: S. anginosus may promote gastric cancer

19 Mar 2024

Risk of nonkeratinocyte skin cancers postradiotherapy high among breast cancer patients

17 Mar 2024

Patients with breast cancer appear to be at increased risk of melanoma and hemangiosarcoma after treatment with radiation therapy, as shown in a study.

Risk of nonkeratinocyte skin cancers postradiotherapy high among breast cancer patients

17 Mar 2024

Men with HR+ breast cancer have high breast cancer─specific mortality risk at 20 years

13 Mar 2024 by

Breast cancer–specific mortality (BCSM) risk remains high over 20 years in men with stage I─III hormone receptor (HR)–positive breast cancer and the kinetics are different from those seen in women, a population-based study has shown.

Men with HR+ breast cancer have high breast cancer─specific mortality risk at 20 years

13 Mar 2024

Strong public policies can prevent alcohol-related diseases, deaths

11 Mar 2024 by

An alcohol preparedness index (API) can help assess the establishment and strength of alcohol-related public health policies across the globe, according to a study.

Strong public policies can prevent alcohol-related diseases, deaths

11 Mar 2024

Simple, radical hysterectomies for low-risk cervical cancer yield similar recurrence rate

11 Mar 2024

Simple hysterectomy shows noninferiority over radical hysterectomy for patients with low-risk cervical cancer, with no significant difference in the 3-year incidence of pelvic recurrence, while reducing the risk of urinary incontinence or retention, according to the phase III CX.5 SHAPE trial.

Simple, radical hysterectomies for low-risk cervical cancer yield similar recurrence rate

11 Mar 2024

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

10 Mar 2024

Pregnant moms who use tobacco, alcohol, marijuana, or cocaine may be putting their babies at risk of several types of cancer, including nonglioma central nervous system tumours and non-Hodgkin lymphoma, as shown in a study.

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

10 Mar 2024

Computer-aided detection of colonic neoplasia yields modest improvements

08 Mar 2024

The use of real-time, computer-aided detection of colonic neoplasia leads to modest increases in adenoma detection rate and adenomas detected per colonoscopy in average-detector community endoscopists, as shown in the results of a pragmatic randomized controlled trial.

Computer-aided detection of colonic neoplasia yields modest improvements

08 Mar 2024

Autocontouring a transformative leap in radiotherapy

07 Mar 2024 by

Dr Aminudin Rahman Mohd Mydin, a consultant clinical oncologist, talks about the role of artificial intelligence (AI) in oncology and the advent of auto-contouring via the application of AI in radiotherapy.

Autocontouring a transformative leap in radiotherapy

07 Mar 2024

Original New Drug Application Approvals by US FDA (16-29 February 2024)

06 Mar 2024

New drug applications approved by US FDA as of 16-29 February 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-29 February 2024)

06 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage

Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage

New pathogen on the block: S. anginosus may promote gastric cancer

New pathogen on the block: S. anginosus may promote gastric cancer

Risk of nonkeratinocyte skin cancers postradiotherapy high among breast cancer patients

Risk of nonkeratinocyte skin cancers postradiotherapy high among breast cancer patients

Men with HR+ breast cancer have high breast cancer─specific mortality risk at 20 years

Men with HR+ breast cancer have high breast cancer─specific mortality risk at 20 years

Strong public policies can prevent alcohol-related diseases, deaths

Strong public policies can prevent alcohol-related diseases, deaths

Simple, radical hysterectomies for low-risk cervical cancer yield similar recurrence rate

Simple, radical hysterectomies for low-risk cervical cancer yield similar recurrence rate

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

Illicit drug, substance use during pregnancy linked to risk of malignancies in offspring

Computer-aided detection of colonic neoplasia yields modest improvements

Computer-aided detection of colonic neoplasia yields modest improvements

Autocontouring a transformative leap in radiotherapy

Autocontouring a transformative leap in radiotherapy

Original New Drug Application Approvals by US FDA (16-29 February 2024)

Original New Drug Application Approvals by US FDA (16-29 February 2024)